, /PRNewswire/ -- DarioHealth Corp. (Nasdaq: ) ("Dario", "DarioHealth" or the "Company"), a leader in the global digital health market, announced today a strategic reorganization designed to streamline leadership and focus the organization on accelerating its commercialization efforts. This move reflects the Company's commitment to bringing its innovative solutions to the market faster, maximizing customer impact, and driving the organization to profitability.
To achieve this goal, DarioHealth is transitioning to a flatter organizational model. The President role will be eliminated, and dedicated C-level positions will be established for each core function, reporting directly to the Chief Executive Officer. The newly created role of Chief Commercial Officer (CCO) will be in addition to the existing C-Level roles in the Company.
The Company believes that this structure fosters a more collaborative environment and ensures clear lines of communication which are essential for driving successful commercialization initiatives. Further strengthening its commercial focus, DarioHealth is excited to announce the appointment of as its Chief Commercial Officer of DarioHealth, Mr. Nelson will be instrumental in developing and executing strategies to drive rapid commercialization.
Mr. Nelson will oversee Dario's global commercial activities, including growth strategy, sales, client management, marketing, strategic partnerships, and expansion into new markets. Mr.
Nelson brings over two dec.
